133 related articles for article (PubMed ID: 22075446)
21. Insight into the effect of inhibitor resistant S130G mutant on physico-chemical properties of SHV type beta-lactamase: a molecular dynamics study.
Baig MH; Sudhakar DR; Kalaiarasan P; Subbarao N; Wadhawa G; Lohani M; Khan MK; Khan AU
PLoS One; 2014; 9(12):e112456. PubMed ID: 25479359
[TBL] [Abstract][Full Text] [Related]
22. 4-Substituted trinems as broad spectrum beta-lactamase inhibitors: structure-based design, synthesis, and biological activity.
Plantan I; Selic L; Mesar T; Anderluh PS; Oblak M; Prezelj A; Hesse L; Andrejasic M; Vilar M; Turk D; Kocijan A; Prevec T; Vilfan G; Kocjan D; Copar A; Urleb U; Solmajer T
J Med Chem; 2007 Aug; 50(17):4113-21. PubMed ID: 17665896
[TBL] [Abstract][Full Text] [Related]
23. Molecular dynamics simulations of the TEM-1 beta-lactamase complexed with cephalothin.
Díaz N; Suárez D; Merz KM; Sordo TL
J Med Chem; 2005 Feb; 48(3):780-91. PubMed ID: 15689162
[TBL] [Abstract][Full Text] [Related]
24. On 3LEZ, a deep-sea halophilic protein with in vitro class-a β-lactamase activity: molecular-dynamics, docking, and reactivity simulations.
Pietra F
Chem Biodivers; 2012 Dec; 9(12):2659-84. PubMed ID: 23255440
[TBL] [Abstract][Full Text] [Related]
25. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
Pérez-Llarena FJ; Cartelle M; Mallo S; Beceiro A; Pérez A; Villanueva R; Romero A; Bonnet R; Bou G
J Antimicrob Chemother; 2008 Apr; 61(4):792-7. PubMed ID: 18281307
[TBL] [Abstract][Full Text] [Related]
26. A novel extended-spectrum TEM-type beta-lactamase, TEM-138, from Salmonella enterica serovar Infantis.
Chouchani C; Berlemont R; Masmoudi A; Galleni M; Frere JM; Belhadj O; Ben-Mahrez K
Antimicrob Agents Chemother; 2006 Sep; 50(9):3183-5. PubMed ID: 16940125
[TBL] [Abstract][Full Text] [Related]
27. Structure and dynamics of CTX-M enzymes reveal insights into substrate accommodation by extended-spectrum beta-lactamases.
Delmas J; Chen Y; Prati F; Robin F; Shoichet BK; Bonnet R
J Mol Biol; 2008 Jan; 375(1):192-201. PubMed ID: 17999931
[TBL] [Abstract][Full Text] [Related]
28. TEM beta-lactamase mutants hydrolysing third-generation cephalosporins. A kinetic and molecular modelling analysis.
Raquet X; Lamotte-Brasseur J; Fonzé E; Goussard S; Courvalin P; Frère JM
J Mol Biol; 1994 Dec; 244(5):625-39. PubMed ID: 7990143
[TBL] [Abstract][Full Text] [Related]
29. Crystal structures of the class D beta-lactamase OXA-13 in the native form and in complex with meropenem.
Pernot L; Frénois F; Rybkine T; L'Hermite G; Petrella S; Delettré J; Jarlier V; Collatz E; Sougakoff W
J Mol Biol; 2001 Jul; 310(4):859-74. PubMed ID: 11453693
[TBL] [Abstract][Full Text] [Related]
30. A theoretical study on the substrate deacylation mechanism of class C beta-lactamase.
Hata M; Tanaka Y; Fujii Y; Neya S; Hoshino T
J Phys Chem B; 2005 Aug; 109(33):16153-60. PubMed ID: 16853052
[TBL] [Abstract][Full Text] [Related]
31. Increased folding stability of TEM-1 beta-lactamase by in vitro selection.
Kather I; Jakob RP; Dobbek H; Schmid FX
J Mol Biol; 2008 Oct; 383(1):238-51. PubMed ID: 18706424
[TBL] [Abstract][Full Text] [Related]
32. Crystal structure of the E166A mutant of extended-spectrum beta-lactamase Toho-1 at 1.8 A resolution.
Ibuka A; Taguchi A; Ishiguro M; Fushinobu S; Ishii Y; Kamitori S; Okuyama K; Yamaguchi K; Konno M; Matsuzawa H
J Mol Biol; 1999 Feb; 285(5):2079-87. PubMed ID: 9925786
[TBL] [Abstract][Full Text] [Related]
33. Structural insights into substrate recognition and product expulsion in CTX-M enzymes.
Delmas J; Leyssene D; Dubois D; Birck C; Vazeille E; Robin F; Bonnet R
J Mol Biol; 2010 Jul; 400(1):108-20. PubMed ID: 20452359
[TBL] [Abstract][Full Text] [Related]
34. Unexpected enzyme TEM-126: role of mutation Asp179Glu.
Delmas J; Robin F; Bittar F; Chanal C; Bonnet R
Antimicrob Agents Chemother; 2005 Oct; 49(10):4280-7. PubMed ID: 16189109
[TBL] [Abstract][Full Text] [Related]
35. On the structural affinity of macromolecules with different biological properties: molecular dynamics simulations of a series of TEM-1 mutants.
Giampaolo AD; Mazza F; Daidone I; Amicosante G; Perilli M; Aschi M
Biochem Biophys Res Commun; 2013 Jul; 436(4):666-71. PubMed ID: 23770365
[TBL] [Abstract][Full Text] [Related]
36. Elimination of the hydrolytic water molecule in a class A beta-lactamase mutant: crystal structure and kinetics.
Zawadzke LE; Chen CC; Banerjee S; Li Z; Wäsch S; Kapadia G; Moult J; Herzberg O
Biochemistry; 1996 Dec; 35(51):16475-82. PubMed ID: 8987980
[TBL] [Abstract][Full Text] [Related]
37. Inactivation of TEM-1 by avibactam (NXL-104): insights from quantum mechanics/molecular mechanics metadynamics simulations.
Sgrignani J; Grazioso G; De Amici M; Colombo G
Biochemistry; 2014 Aug; 53(31):5174-85. PubMed ID: 25050826
[TBL] [Abstract][Full Text] [Related]
38. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
[TBL] [Abstract][Full Text] [Related]
39. Engineering an allosteric binding site for aminoglycosides into TEM1-β-Lactamase.
Volkov AN; Barrios H; Mathonet P; Evrard C; Ubbink M; Declercq JP; Soumillion P; Fastrez J
Chembiochem; 2011 Apr; 12(6):904-13. PubMed ID: 21425229
[TBL] [Abstract][Full Text] [Related]
40. Molecular docking programs successfully predict the binding of a beta-lactamase inhibitory protein to TEM-1 beta-lactamase.
Strynadka NC; Eisenstein M; Katchalski-Katzir E; Shoichet BK; Kuntz ID; Abagyan R; Totrov M; Janin J; Cherfils J; Zimmerman F; Olson A; Duncan B; Rao M; Jackson R; Sternberg M; James MN
Nat Struct Biol; 1996 Mar; 3(3):233-9. PubMed ID: 8605624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
